Fierce Health Technology June 11, 2020
Precision medicine holds significant promise for cancer care but may be out of reach for minority populations due to a lack of diversity among participants in clinical trials.
That’s why cancer research nonprofit Stand Up To Cancer (SU2C) recently launched a new committee led by oncology experts to push for more equitable representation in research for new cancer treatments.
Edith Perez, M.D., an oncologist with Mayo Clinic and the chairperson of Committee for Health Equity in Cancer Clinical Trials, told Fierce Healthcare that the lack of participants of color in clinical trials prevents researchers from getting the full picture of how socioeconomic factors impact their health outcomes, which are often worse than white patients.
The lack of...
Today's Sponsors
Today's Sponsor